The importance of vaccination and immunoglobulin treatment for patients with primary immunodeficiency diseases (PIDs) ‐ World PI Week April 22–29, 2015

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 1285-1286

John Wiley & Sons Inc

Access to resources Recommend Favorite

An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease

By  

VOX SANGUINIS, Vol. 109, Iss. 3, 2015-10 ,pp. : 248-256

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunoglobulin G Values before Treatment Are Correlated With the Responsiveness to Initial Intravenous Immunoglobulin Therapy for Kawasaki Disease

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 2, 2014-06 ,pp. : 83-88

Karger

Access to resources Recommend Favorite

Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey

By Froelich Lutz   Andreasen Niels   Tsolaki Magda   Foucher Arnaud   Kavanagh Shane     Schwalen Susanne  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3059-3068

Informa Healthcare

Access to resources Recommend Favorite

Adolescent Primary Care Patients’ Preferences for Depression Treatment

By Jaycox Lisa   Asarnow Joan   Sherbourne Cathy   Rea Margaret   LaBorde Anne   Wells Kenneth  

Administration and Policy in Mental Health, Vol. 33, Iss. 2, 2006-03 ,pp. : 198-207

Springer Publishing Company

Access to resources Recommend Favorite